Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01232816|
Recruitment Status : Active, not recruiting
First Posted : November 2, 2010
Last Update Posted : September 14, 2016
|Condition or disease|
|Delayed Graft Function|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Can T Helper 17 and Regulatory T Cells Explain the Pathophysiology of Delayed Graft Function in Renal Transplant Recipients?|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2019|
Delayed graft function
These are patients in whom dialysis is required following transplantation.
These are patients in whom no dialysis is required and creatinine declines by >20% in the first 24 hours following transplantation.
- Graft function [ Time Frame: 1 year ]Kidney graft function as measured by GFR
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01232816
|McGill University Health Center|
|Montreal, Quebec, Canada, H3A 1A1|
|Principal Investigator:||Steven Paraskevas, MD PhD||McGill University Health Center|